246 studies found for:    "Whooping cough"
Show Display Options
Rank Status Study
21 Completed First Adult Safety Trial on Nasal Live Attenuated B. Pertussis Vaccine
Condition: Pertussis
Interventions: Biological: BPZE1;   Biological: Placebo
22 Completed
Has Results
Study of Quinvaxem for Vaccination Against Diphtheria, Pertussis, Tetanus, Hepatitis B and Diseases Caused by Haemophilus Influenzae Type B
Conditions: Diphtheria;   Pertussis;   Tetanus;   Hepatitis B;   Haemophilus Influenzae Infections
Intervention: Biological: Quinvaxem
23 Recruiting Seroepidemiological Study of Pertussis and Other Infectious Diseases
Condition: Pertussis Infection
Intervention:
24 Completed Safety and Immunogenicity Study of Concomitant Versus Non Concomitant Administration of a Diphtheria, Tetanus, Pertussis and Poliomyelitis Vaccine (REPEVAX) and Influenza Vaccine (VAXIGRIP) in Subjects Aged From 60 Years Old
Conditions: Diphtheria;   Tetanus;   Pertussis;   Poliomyelitis
Interventions: Biological: Concomitant administration;   Biological: Separate administration
25 Completed Safety and Immunogenicity Study of a Diphtheria, Tetanus, Acellular Pertussis and Poliomyelitis Vaccine (REPEVAX) Followed by 2 Doses of a Diphtheria, Tetanus and Poliomyelitis Vaccine (REVAXIS) in Subjects of 40 Years of Age or Older
Conditions: Diphtheria;   Tetanus;   Poliomyelitis;   Pertussis
Intervention: Biological: Diphtheria, tetanus, polio and pertussis vaccination
26 Completed
Has Results
Safety and Immune Response of Different Pediatric Combination Vaccines.
Conditions: Diphtheria;   Polio;   Pertussis
Interventions: Biological: DAPTACEL®. (DTaP), IPOL®., and ActHIB®.;   Biological: Pentacel®: DTaP-IPV/Hib combined;   Biological: DTaP-IPV and ActHIB®
27 Completed
Has Results
Concomitant Use of Gardasil (V501, Human Papillomavirus [Types 6, 11, 16, 18] Recombinant Vaccine) With Combined Diptheria, Tetanus, Pertussis and Poliomyelitis Vaccine in Adolescents (V501-024)(COMPLETED)
Conditions: Neoplasms, Glandular and Epithelial;   Diphtheria;   Tetanus;   Whooping Cough;   Poliomyelitis
Interventions: Biological: Comparator: Quadrivalent Human Papillomavirus (Types 6, 11, 16, 18) Recombinant (qHPV) Vaccine from Current Manufacturing Facility (CMF);   Biological: Comparator: Quadrivalent Human Papillomavirus (Types 6, 11, 16, 18) Recombinant (qHPV) Vaccine from Future Manufacturing Facility (FMF);   Biological: Comparator: REPEVAX™ (Concomitant);   Biological: Comparator: REPEVAX™ (Non-Concomitant)
28 Completed
Has Results
Concomitant Use of Gardasil (V501) (Human Papillomavirus [Types 6, 11, 16, 18] Recombinant Vaccine) With Combined Diphtheria, Tetanus, Pertussis Vaccine and Meningococcal Conjugate Vaccine in Adolescents (V501-025)
Conditions: Neoplasms, Glandular and Epithelial;   Diphtheria;   Tetanus;   Whooping Cough;   Meningitis
Interventions: Biological: Comparator: Quadrivalent Human Papillomavirus (HPV) vaccine;   Biological: Comparator: Menactra™ (Concomitant);   Biological: Comparator: Adacel™ (Concomitant);   Biological: Comparator: Menactra™ (Non-concomitant);   Biological: Comparator: Adacel™
29 Active, not recruiting Vouchers to Promote Tdap Vaccination
Condition: Whooping Cough
Interventions: Other: Full price;   Other: $5 off
30 Completed A Study of DTaP-IPV-Hep B-PRP-T Vaccine Given With Prevenar™ and Rotarix™ in Healthy Latin American Infants
Conditions: Diphtheria;   Tetanus;   Whooping Cough;   Hepatitis B;   Poliomyelitis
Interventions: Biological: DTaP-IPV-Hep B-PRP-T Vaccine;   Biological: DTaP-Hep B-IPV vaccine
31 Completed Antibody Persistence in Healthy Children After Primary and Booster DTaP-IPV-Hep B-PRP-T Vaccine or Control Vaccine
Conditions: Diphtheria;   Tetanus;   Whooping Cough;   Hepatitis B;   Poliomyelitis
Intervention:
32 Completed Study of DTap-IPV Compared to DAPTACEL® and IPOL® as the 5th Dose in Children 4 to 6 Years of Age
Conditions: Tetanus;   Diphtheria;   Pertussis;   Measles;   Polio
Interventions: Biological: Diphtheria and Tetanus Toxoids and Acellular Pertussis + Measles, Mumps, Rubella + Varicella Virus;   Biological: Diphtheria and Tetanus Toxoids and Acellular Pertussis + Poliovirus + MMR + Varicella Virus
33 Withdrawn A Study of the Immunogenicity and Safety of Whole-Cell Pertussis Containing Vaccine Administered Concomitantly With RotaTeq™ (V260) or Rotarix™ (V260-036)(WITHDRAWN)
Conditions: Rotavirus Gastroenteritis;   Diphtheria;   Tetanus;   Pertussis
Interventions: Biological: Rotavirus Vaccine, Live, Oral, Pentavalent;   Biological: Comparator: Rotarix™ administered concomitantly with Tritanrix™ HepB (DTwP);   Biological: Comparator: RotaTeq™ administered concomitantly with INFANRIX™ (DTaP)
34 Completed Assess Feasibility of an Acellular Pertussis Vaccine (Pa) Given Soon After Birth, Followed by 3-dose Primary Vaccination With the DTPa-HBV-IPV/Hib Vaccine
Conditions: Hib Disease;   Poliomyelitis;   Hepatitis B;   Diphtheria;   Pertussis;   Tetanus
Interventions: Biological: Pertussis vaccine;   Biological: DTPa-HBV-IPV/Hib
35 Enrolling by invitation Antibody Persistence at Age 3.5 and 4.5 Years After Primary and Booster DTaP-IPV-Hep B-PRP~T or Infanrix Hexa Vaccination
Conditions: Diphtheria;   Tetanus;   Whooping Cough;   Hepatitis B;   Poliomyelitis;   Haemophilus Influenzae Type b
Interventions: Biological: DTaP-IPV-Hep B- PRP~T + Prevenar + Rotarix vaccine;   Biological: DTaP- IPV-Hep B-PRP~T + Prevenar + Rotarix + Infanrix hexa vaccine;   Biological: Infanrix hexa + Prevenar + Rotarix vaccine
36 Completed Study of the Booster Effect of DTaP-IPV-Hep B-PRP-T Combined Vaccine or Infanrix Hexa™ and Prevenar™ in Healthy Infants
Conditions: Diphtheria;   Tetanus;   Whooping Cough;   Hepatitis B;   Poliomyelitis
Interventions: Biological: DTaP-IPV-Hep B-PRP-T combined vaccine + Pneumococcal polysaccharide;   Biological: DTaP-Hep B-IPV // Hib Vaccine + Pneumococcal polysaccharide;   Biological: DTaP-IPV-Hep B-PRP-T + Pneumococcal polysaccharide vaccine
37 Recruiting Study of DTaP-IPV-Hep B-PRP~T Combined Vaccine in Indian Infants Previously Given a Dose of Hepatitis B Vaccine at Birth
Conditions: Diphtheria;   Tetanus;   Whooping Cough;   Hepatitis B;   Poliomyelitis;   Invasive Hib Infections
Intervention: Biological: Hexaxim™: DTaP-IPV-Hep B-PRP~T combined vaccine
38 Completed Seroprevalence Study of Hepatitis A, Varicella-Zoster, Cytomegalovirus, Herpes Simplex and Bordetella Pertussis
Conditions: Viral Hepatitis Vaccines;   Hepatitis A;   Cytomegalovirus;   Varicella-Zoster Virus;   Bordetella Pertussis Infection;   Herpes Simplex (1 and 2)
Intervention: Other: Serum sample
39 Completed
Has Results
Evaluation of GlaxoSmithKline Biologicals' Boostrix® Vaccine in Comparison With Decavac™ Vaccine.
Conditions: Diphtheria;   Pertussis;   Diphtheria-Tetanus-acellular Pertussis Vaccines;   Tetanus
Interventions: Biological: Boostrix®;   Biological: Decavac™
40 Completed Assessment of GSK Biologicals' Tdap Candidate Vaccine Administered as a Booster (6th Dose) in Terms of Immunogenicity and Safety to Children and Adolescents Previously Vaccinated With Five Doses of an Acellular Pertussis-containing Vaccine.
Condition: Prophylaxis: Diphtheria, Tetanus and Pertussis
Intervention: Biological: Prophylaxis: Diphtheria, tetanus and pertussis

Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results
Indicates status has not been verified in more than two years